On the Frontlines of Psoriasis

Guest: Christopher Bunick, MD, PhD, FAAD

Host: Ryan Quigley


With high selectivity, durable response, and once-daily dosing, next-generation TYK2 inhibitors offer a promising oral option for patients with moderate-to-severe plaque psoriasis. Ryan Quigley sits down with Dr. Christopher Bunick, Associate Professor of Dermatology and Translational Biomedicine at Yale University School of Medicine, to learn more about how these agents may align with evolving patient preferences and expand options beyond injectables.

Host: Ryan Quigley

Guest: Michael Greenberg, MD


A patient’s inner dialogue—especially negative self-talk—can influence their perception of disease, adherence to treatment, and emotional wellbeing. Ryan Quigley sits down with Dr. Michael Greenberg, a dermatologist at the Illinois Dermatology Institute, as he shares observations from his own practice, highlighting how recognizing subtle emotional cues and practicing empathetic communication can help support more holistic and sustainable outcomes in psoriasis.

Guest: Peter Lio, MD

Host: Ryan Quigley


Flare patterns, patient concerns, and growing research have brought diet to the forefront of psoriasis care. Tune in as Dr. Peter Lio reviews the strongest evidence behind weight management, gluten sensitivity, and anti-inflammatory nutrition, offering clarity on how diet can support—though not replace—primary treatments. Dr. Lio is a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a dermatologist at Medical Dermatology Associates of Chicago.

New research highlights what patients with psoriasis really want to know about family planning and pregnancy—and when they want to hear it. Discover how proactively addressing these topics can close communication gaps, improve outcomes, and empower patients during this critical life stage with host Ryan Quigley and Ms. Liana Barenbrug, a PhD candidate at Radboud University Medical Center in the Netherlands.

Guest: Audrey Bui, DO


Genetic insights are reshaping how we understand the development and comorbidities of psoriasis, as well as treatment response in patients. Hear Dr. Audrey Bui discuss how genetic variants influence risks for certain conditions, how they may predict response to therapies like methotrexate, ustekinumab, and IL-17 inhibitors, and how integrating genetic markers into clinical care can enable more targeted, effective psoriasis management. Dr. Bui is a recent graduate from Lake Erie College of Osteopathic Medicine and an intern at the University of Central Florida prior to starting her dermatology residency at Hackensack Meridian Health Palisades Medical Center.